Nath Is making it clear NIH has essentially replaced researching ME/CFS with long covid, which He bizarrely describes as much more severe.
Who will challenge this attitude &approach &speak up for those with #MECFS ill 40 years? He actually says it would be miserable for pwLC to be ill for forty years when NIH have left pw ME/CFS to that fate, hv barely done even rudimentary research, for eg in PEM, over that time &now wants to replace ME with LC
Who will challenge this further?
non-Covid ME research should Have a research prog of its own as well as being studied alongside LC, including in clinical trials, & getting separate campaigns from the orgs. Isn’t Merging as IACC just facilitating this type of NIH approach, not tempering it? ME subgroups/ triggers, advanced stages & severity deserve focused research, just as MS & Parkinson's, with smaller numbers Affected, get the full spectrum of research their communities need - from early intervention to reversing years of damage. A Covid antiviral isn’t the answer for ME.
NIH, out of the other side of their mouth, say they’re not sure yet ME = LC &ME has a variance in trigger, chronicity & damage that make it harder to treat. A simple fact is that the 2 cohorts in the length of time Ill, management History (amount of harm) & trigger are different, so to substitute ME almost entirely with LC is Unjustified & imo Self-serving after years of neglect
Who will challenge this attitude &approach &speak up for those with #MECFS ill 40 years? He actually says it would be miserable for pwLC to be ill for forty years when NIH have left pw ME/CFS to that fate, hv barely done even rudimentary research, for eg in PEM, over that time &now wants to replace ME with LC
Who will challenge this further?
non-Covid ME research should Have a research prog of its own as well as being studied alongside LC, including in clinical trials, & getting separate campaigns from the orgs. Isn’t Merging as IACC just facilitating this type of NIH approach, not tempering it? ME subgroups/ triggers, advanced stages & severity deserve focused research, just as MS & Parkinson's, with smaller numbers Affected, get the full spectrum of research their communities need - from early intervention to reversing years of damage. A Covid antiviral isn’t the answer for ME.
NIH, out of the other side of their mouth, say they’re not sure yet ME = LC &ME has a variance in trigger, chronicity & damage that make it harder to treat. A simple fact is that the 2 cohorts in the length of time Ill, management History (amount of harm) & trigger are different, so to substitute ME almost entirely with LC is Unjustified & imo Self-serving after years of neglect
Last edited by a moderator: